4 Canadian Marijuana Stocks with Appealing Price-to-Book Multiples

The Canadian marijuana stocks on our list have the lowest price-to-book multiples amongst their peers

SmallCapPower | May 31, 2019: Today we have weeded out four Canadian marijuana stocks that have the lowest price-to-book multiple in the sector. The selected cannabis stocks have a market capitalization in the range of $15 million to $160 million.

*Market caps based on the closing price on May 28, 2019.

For Our Complete Coverage Of Canadian Marijuana Stocks Click Here     

Isodiol International Inc. (CSE:ISOL) – $1.31

Isodiol International is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based Consumer Packaged Goods (CPG) and solutions. Isodiol has commercialized a 99%+ pure, naturally-isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skincare products. On May 16, 2019, the Company issued updates on its Mexico operations and restructuring efforts. Isodiol looks forward to the issuance of new regulations and licenses in Mexico, authorizing the distribution and sale of CBD-based medical products and CPG.

  • Price-to-book multiple: 0.58x
  • Market Cap: $63.2 Million

Abattis Bioceuticals Corp. (CSE:ATT) – $0.08

Abattis Bioceuticals is a life sciences and biotechnology company, which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets.

  • Price-to-book multiple: 0.47x
  • Market Cap: $18.4 Million

SOL Global Investment Corp. (CSE:SOL) – $2.48

SOL Global is an international investment company with a focus on the cannabis industry in legal U.S. states. It has strategic investments and partnerships across cultivation, distribution and retail, which complement the Company’s R&D program with the University of Miami. On May 23, 2019, the Company announced that its portfolio company, Heavenly Rx. Ltd., has closed a US$30.06 million investment in Blühen Botanicals, an industry-leading hemp and hemp-derived CBD biomass farming, processing, extraction and retail company headquartered in Knoxville, Tennessee.

  • Price-to-book multiple: 0.61
  • Market Cap: $135.2 Million

Captor Capital Corp. (CSE:CPTR) – $1.25

Captor Capital is a vertically-integrated cannabis company that cultivates, manufactures and distributes recreational and medical marijuana based products to consumers through its leading brands and dispensary retail stores.

  • Price-to-book multiple: 0.48x
  • Market Cap: $49.5 Million

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: